SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibodies Share News (FAB)

Share Price Information for Fusion Antibodies (FAB)

Share Price is delayed by 15 minutes
Get Live Data
12.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (8.696%)
Market Cap: £15.02m
FAB Live PriceLast checked at - London Stock Exchange

Intraday Fusion Antibodies Share Chart

Fusion Antibodies News

Fusion Antibodies receives approval of grant funding application
4 Dec 2024

Fusion Antibodies receives approval of grant funding application

(Alliance News) - Fusion Antibodies PLC on Wednesday announced the approval of a grant funding application to The Northern Ireland Precision Biomarker...

Fusion Antibodies interim loss narrows as revenue more than doubles
19 Nov 2024

Fusion Antibodies interim loss narrows as revenue more than doubles

(Alliance News) - Fusion Antibodies PLC on Tuesday said its loss narrowed in the first half of its current financial year, as revenue more than double...

Fusion Antibodies reports positive recent trading
8 Oct 2024

Fusion Antibodies reports positive recent trading

(Sharecast News) - Fusion Antibodies reported positive trading in an update on Tuesday, highlighting significant progress for the first half of its fi...

IN BRIEF: Fusion Antibodies expects interim revenue to double
8 Oct 2024

IN BRIEF: Fusion Antibodies expects interim revenue to double

Fusion Antibodies PLC - Belfast-based contract researcher that provides discovery, design and optimisation services for therapeutic antibodies to the ...

Fusion Antibodies strengthens financial position despite revenue decline
5 Sep 2024

Fusion Antibodies strengthens financial position despite revenue decline

(Sharecast News) - Preclinical antibody discovery and engineering specialist Fusion Antibodies said in its final results on Thursday that despite a ch...

Fusion Antibodies expands agreement with National Cancer Institute
28 Aug 2024

Fusion Antibodies expands agreement with National Cancer Institute

(Alliance News) - Fusion Antibodies PLC on Wednesday said it is expanding its collaboration agreement with the National Cancer Institute.

AIM WINNERS & LOSERS: Aquis expects GBP1 million hit on contract loss
28 Aug 2024

AIM WINNERS & LOSERS: Aquis expects GBP1 million hit on contract loss

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday.